⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9637859 | 1.00 | — | — | |
| SCHEMBL12238830 | 0.81 | — | — | |
| SCHEMBL9637730 | 0.78 | FOLH1 (0.43) | — | |
| SCHEMBL11000750 | 0.78 | — | — | |
| SCHEMBL9586717 | 0.75 | RNPEP (0.38) | — | |
| SCHEMBL9392724 | 0.75 | CHRM1 (0.41) | — | |
| SCHEMBL9638452 | 0.74 | FOLH1 (0.47) | — | |
| SCHEMBL7287344 | 0.73 | — | — | |
| SCHEMBL13225821 | 0.73 | ENPEP (0.40) | — | |
| SCHEMBL157028 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534324-B1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2019-01-16 | — | — | EP | disclosed |
| US-20180055928-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2018-03-01 | — | — | US | disclosed |
| US-20140234318-A1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2014-08-21 | — | — | US | disclosed |
| US-8697061-B2 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2014-04-15 | — | — | US | disclosed |
| EP-2322209-A2 | Tumor specific oligosaccharide epitopes and use thereof | Glykos Finland Oy (FI) | 2011-05-18 | — | — | EP | disclosed |
| US-20060014672-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2006-01-19 | — | — | US | disclosed |
| EP-1534324-A2 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | BioTie Therapies Ltd. (FI) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004017810-A2 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | BIOTIE THERAPIES CORP. (FI) | 2004-03-04 | — | — | WO | disclosed |
| US-5830888-A | Macrocyclic retroviral protease inhibitors | MONSANTO COMPANY (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0850230-A1 | PYRROLIDINE AND THIAZOLE DERIVATIVES WITH ANTIBACTERIAL AND METALLO-BETA-LACTAMASE INHIBITORY PROPERTIES | SMITHKLINE BEECHAM PLC (GB) | 1998-07-01 | — | — | EP | disclosed |
| WO-1997010225-A1 | PYRROLIDINE AND THIAZOLE DERIVATIVES WITH ANTIBACTERIAL AND METALLO-BETA-LACTAMASE INHIBITORY PROPERTIES | SMITHKLINE BEECHAM PLC (GB) | 1997-03-20 | — | — | WO | disclosed |